Cognition | Jotup

Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease

Retrieved on:

tisdag, mars 12, 2024

“Pridopidine demonstrates consistent treatment benefits across independent measures that are important to patients and families.

Key Points:

“Pridopidine demonstrates consistent treatment benefits across independent measures that are important to patients and families.
The benefits are clearly evident in those with HD who are not taking anti-dopaminergic medications (ADM),” said Dr. Michael R. Hayden, CEO of Prilenia.
“We appreciate the constructive discussions with European regulators regarding our data for pridopidine.
The Company will also consider global regulatory submissions for additional countries and regions following the regulatory review process in Europe.

air up®'s April Fools Campaign Sheds Light On Americans' Peeing Habits

Retrieved on:

tisdag, april 2, 2024

Health, Perspiration, Mental health, Fool, Joint, Drinking, Urine, Dehydration, Cognition, Water, Habit, Clutch (eggs), LOS, Sawmill

With this campaign, air up® aimed to spark a national conversation about the importance of proper hydration, particularly in light of the fact that 61% of Americans express current or past concerns about the color of their urine.

Key Points:

With this campaign, air up® aimed to spark a national conversation about the importance of proper hydration, particularly in light of the fact that 61% of Americans express current or past concerns about the color of their urine.
Lena Jüngst, Co-Founder of air up®, explains, "Rest assured, we're not launching a pee-flavored pod.
The attention-grabbing tactic is part of a broader educational campaign to highlight the release of air up's® recent survey shedding light on Americans' peeing habits.
While the findings underscore positive awareness of urine's significance as a marker for hydration and overall health, significant gaps remain.

Bio-K Plus expands its portfolio of functional probiotics with its new Extra Stress Support with Sensoril® probiotic drinkable to meet consumers' demand for science-powered products with multiple benefits

Retrieved on:

torsdag, mars 28, 2024

Research, Health, Kerry Group, Taste, Withania somnifera, Withania, Probiotic, Food, Seed, Marketing, Cognition, Whole Foods Market, Multimedia, Dietary supplement

MONTREAL, March 28, 2024 /PRNewswire/ - Bio-K Plus, a Kerry Company, pioneer in the probiotic sector, is pleased to announce the launch of its new functional drinkable probiotic, the Extra Stress Support with Sensoril®.

Key Points:

MONTREAL, March 28, 2024 /PRNewswire/ - Bio-K Plus, a Kerry Company, pioneer in the probiotic sector, is pleased to announce the launch of its new functional drinkable probiotic, the Extra Stress Support with Sensoril®.
Sensoril® is a plant-based premium ashwagandha extract (withania somnifera) renowned for managing everyday stress and promoting emotional well-being.
All of this is delivered in the form of a delicious lemon and ginger-flavored drinkable probiotic, that tastes like a fresh smoothie.
Source: Market Future Research: Functional Beverages Market Research Report – Market Forecast Till 2023, February 20211
View original content to download multimedia: https://www.prnewswire.com/news-releases/bio-k-plus-expands-its-portfoli...

World's first field-installed, clinically approved parallel transmit 7T MRI scanner resides at Auburn University

Retrieved on:

tisdag, mars 26, 2024

Additionally, with dedicated radiofrequency sodium imaging coils and parallel transmit technology, the scanner offers expanded imaging capabilities.

Key Points:

Additionally, with dedicated radiofrequency sodium imaging coils and parallel transmit technology, the scanner offers expanded imaging capabilities.
These areas represent an intersection between the needs of the MRI research community, particularly in 7T imaging, and existing expertise and strengths of Auburn University.
A stark difference between the old and new 7T scanners involve parallel transmit technology and sodium imaging capability.
"If it wasn't for them, we wouldn't have the 7T, and we are indebted to them for their dedication and commitment to Auburn.

PSA: As Pandemic Pets Enter New Life Stages, Petco Shares Tips for Supporting Pet Health and Wellness

Retrieved on:

onsdag, mars 20, 2024

ASPCA, Health, DVM, Database, Pet, Growth, Bed, COVID-19, SAN, Infection, Vaccine, Calcium, Social anxiety, Human, MBA, Diet, Dog, Skin, Cognition, Safety, Cat, Parent, Hand, Vaccination, Pet industry

SAN DIEGO, March 20, 2024 /PRNewswire/ -- Four years since the onset of COVID-19, puppies and kittens adopted during the pandemic are now entering adulthood and pets adopted as adults are approaching their senior years. As a partner in complete pet care, Petco Health and Wellness Company Inc. (Nasdaq: WOOF) is sharing veterinarian-recommended tips for supporting pets through life stage transitions.

Key Points:

As a partner in complete pet care, Petco Health and Wellness Company Inc. (Nasdaq: WOOF) is sharing veterinarian-recommended tips for supporting pets through life stage transitions.
It's critically important that pet parents understand the varying life stages and how they can help their pets live their healthiest, happiest lives at each milestone."
As pets enter their senior years, a trusted veterinarian can diagnose and treat issues to help pets live longer, healthier lives.
For more information on supporting pet health and wellness through life stage transitions, visit a Petco pet care center or petco.com.

Three Strategies To Combat Media Disinformation Amidst Political Polarization and False Narratives

Retrieved on:

måndag, mars 11, 2024

Logic, Democracy, HH, Communication, Science, News, Politics, Health, Behavior, KBUU-LP, MIP, Cognition, Happiness, LOS, Language, Marketing, Emotion, Carnegie Mellon University

LOS ANGELES, March 11, 2024 /PRNewswire/ -- As the election cycle approaches amidst the current hostile landscape, understanding effective media consumption becomes paramount for Americans. Disinformation is emerging as a strategic campaign tool, influencing outcomes and necessitating a critical understanding of its impact on our democracy.

Key Points:

Masterminds Lisa Cypers Kamen and Andy Norman, share three strategies for decoding disinformation and minimizing its deliberate impact on political outcomes.
LOS ANGELES, March 11, 2024 /PRNewswire/ -- As the election cycle approaches amidst the current hostile landscape, understanding effective media consumption becomes paramount for Americans.
Disinformation is emerging as a strategic campaign tool, influencing outcomes and necessitating a critical understanding of its impact on our democracy.
Individuals are hungry for media literacy and common sense strategies to combat false narratives and safeguard democracy.

The surprising key to magpie intelligence: it’s not genetic

Retrieved on:

onsdag, mars 13, 2024

Bird, Food, Friends, Research, Human, Fledgling, Pleasure, Social environment, Magpie, Intelligence, Mother, Environment, Cognition, Toy

Are their sharp cognitive abilities innate – something coded into their genetic makeup?

Key Points:

Are their sharp cognitive abilities innate – something coded into their genetic makeup?
Or are magpie smarts more a product of their environment and social experiences?
In a new study, we shed light on the “nature versus nurture” debate – at least when it comes to avian intelligence.
Instead, the key factor influencing how quickly the fledglings learned to pick the correct colour was the size of their social group.

Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock

Retrieved on:

tisdag, mars 12, 2024

Titan, Prospectus, Cognition, Sale, Form, Therapy, Public expenditure, Research

PURCHASE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has priced an underwritten public offering of 6,571,428 shares of its common stock at an offering price of $1.75 per share of common stock.

Key Points:

PURCHASE, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has priced an underwritten public offering of 6,571,428 shares of its common stock at an offering price of $1.75 per share of common stock.
Cognition has also granted the underwriters a 30-day option to purchase up to 985,714 additional shares of its common stock sold in the offering on the same terms and conditions.
The Company expects to close the offering on March 14, 2024, subject to the satisfaction of customary closing conditions.
Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the offering.

Cognition Therapeutics Announces Proposed Public Offering of Common Stock

Retrieved on:

måndag, mars 11, 2024

Titan, Prospectus, Cognition, Sale, Form, Therapy, S-3

PURCHASE, N. Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has commenced an underwritten public offering (the “offering”) of shares of its common stock.

Key Points:

PURCHASE, N. Y., March 11, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has commenced an underwritten public offering (the “offering”) of shares of its common stock.
Cognition also intends to grant the underwriter a 30-day option to purchase up to an additional 15% of the aggregate number of shares of its common stock to be sold in the offering.
All of the shares of common stock to be sold in the proposed offering will be sold by Cognition.
Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the proposed offering.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GrafTech, Instacart, Cassava, and Amylyx and Encourages Investors to Contact the Firm

Retrieved on:

lördag, mars 9, 2024

The Company sells and delivers a range of products in the food, alcohol, consumer health, pet care, and ready-made meals categories, in addition to others.

Key Points:

The Company sells and delivers a range of products in the food, alcohol, consumer health, pet care, and ready-made meals categories, in addition to others.
The Company offers its services through a mobile application and website, while also providing software-as-a-service solutions to retailers.
In addition, the complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
For more information on the Amylyx class action go to: https://bespc.com/cases/AMLX